Skip to main content
Colin Hill

Colin Hill
CEO, Chairman, GNS Healthcare

Website

Colin is a frequent speaker at international scientific and industry conferences and has appeared in numerous publications and television segments including The Wall Street Journal, CNBC Morning Call, Nature, Forbes, Wired, and The Economist. He serves as CEO and Chairman of GNS Healthcare’s parent company Via Science, and chairman of the board of Fina Technologies, a subsidiary of Via Science that applies next-generation artificial intelligence technology to real-time financial trading. He also serves on the board of directors of AesRx, a biopharmaceutical company dedicated to the development of a new treatment for sickle cell disease.

In 2004, Colin was named to MIT Technology Review’s TR100 list of the top innovators in the world under the age of 35. He graduated from Virginia Tech with a degree in physics and earned master’s degrees in physics from McGill University and Cornell University.

Sessions

Salon G-F
Julie Steele (Manifold), Colin Hill (GNS Healthcare)
Average rating: ****.
(4.00, 2 ratings)
Opening remarks by Strata Rx program chairs, Julie Steele of O'Reilly Media, Inc. and Colin Hill of GNS Healthcare. Read more.
Salon G-F
Colin Hill (GNS Healthcare), Julie Steele (Manifold)
Strata Rx program chairs, Julie Steele of O'Reilly Media, Inc. and Colin Hill of GNS Healthcare, welcome you to the second day of keynotes. Read more.

For exhibition and sponsorship opportunities at Strata Rx conference, contact Sharon Pierce at (203) 304-9476 or spierce@oreilly.com

For information on trade opportunities with O'Reilly conferences email mediapartners
@oreilly.com

View a complete list of Strata Rx 2013 contacts